Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC-study) - a Phase I/II Trial

NCT03544736 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03544736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03544736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC-study) - a Phase I/II Trial
Lead sponsor
Oslo University Hospital
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
April 26, 2018
Completion date
December 31, 2040
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer